Investigation claims NHS impeding access to hep-c drugs
An investigation published by The BMJ has claimed that the NHS is ‘rationing’ Gilead’s high priced hepatitis C drugs Sovaldi and Harvoni.
Read More
Search Results for: Dr Andrew Ustianowski
How the elimination of HCV in England could become a reality
England has many hurdles to overcome before hepatitis C can be eliminated, but there are rays of hope
Read More
MSD launches once-daily Isentress in the UK
Will be better placed to compete head on with ViiV’s rival integrase inhibitor Tivicay
Read More
‘Mix and match’ COVID-19 vaccine study yields promising results
Mixing different vaccines produces a strong immune response against virus, according to researchers
Read More- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
